Trial Profile
Prospective, randomized, double-blind, controlled trial of the healing effect of Polaprezinc for NSAIDs induced small bowel injury
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2015
Price :
$35
*
At a glance
- Drugs Polaprezinc (Primary)
- Indications NSAID-induced gastrointestinal damage
- Focus Therapeutic Use
- 02 Dec 2008 New trial record.